Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
3.
Occup Ther Health Care ; 35(2): 198-216, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33794730

ABSTRACT

Self-management programs are used to assist stroke survivors to manage their condition and participation. This study was designed to examine correlations between occupational identity and outcomes of participation-focused self-management program using the Occupational Performance History Interview for the occupational identity and participation and self-efficacy as outcome measures. Spearman's rho correlations were calculated between occupational Identity and the program's outcomes. Results showed moderate significant positive correlations with self-efficacy for self-management and self-efficacy for participation scales at baseline; few were found at post-intervention and follow-up. Non-significant correlations were found between occupational identity and the change in outcome measures from baseline to post-intervention and to follow-up. Findings suggest occupational identity is strongly related to self-efficacy after stroke, and less related to intervention outcomes. However, other factors may possibly affect the effectiveness of self-management programs for a stroke population. Exploration of these factors might help develop programs better tailored to each stroke survivor.


Subject(s)
Occupational Therapy , Occupations , Self-Management/methods , Stroke Rehabilitation/methods , Humans , Self Efficacy
4.
Top Stroke Rehabil ; 27(8): 577-589, 2020 12.
Article in English | MEDLINE | ID: mdl-32174261

ABSTRACT

Background: Stroke survivors find it difficult to participate in daily activities, despite their improvement throughout the rehabilitation process. Thus, it has been questioned whether day-rehabilitation services provide adequate preparation for participation and reintegration into the community. Self-management programs can improve survivors' self-efficacy to manage their condition and participation. Improving Participation After Stroke Self-Management program (IPASS) is an occupational therapy-based group intervention developed in the United States, which has been effective in improving participation outcomes.Objective: To evaluate the feasibility and effectiveness of the IPASS adapted for an Israeli population of individuals admitted to a day-rehabilitation center after stroke.Methods: A single-center, randomized, assessor-blind study was conducted. Eligible participants were randomized to receive the IPASS (intervention group), in addition to standard individual therapy or standard care only (control group). Feasibility was based on attendance rate and a feedback questionnaire. Effectiveness was evaluated with the Functional Independence Measure (FIM), the Reintegration to Normal Living Index (RNLI) and self-efficacy questionnaires.Results: Sixty participants were included, of which 39 completed baseline and post-intervention evaluations. The intervention group improved significantly in the FIM scores (p < .01), as compared to the control group (p > .05). Moderate effect sizes (≥0.35) were found for the FIM and RNLI, and large effect sizes (≥0.65) for two subcategories in the participation self-efficacy questionnaire.Conclusions: The results support the feasibility of the adapted IPASS, and show a trend for positive effects in improving participation and self-efficacy in managing participation in home and community activities, for an Israeli post-stroke population.


Subject(s)
Self-Management , Stroke Rehabilitation , Stroke , Feasibility Studies , Humans , Pilot Projects
5.
Educ Health (Abingdon) ; 32(2): 79-83, 2019.
Article in English | MEDLINE | ID: mdl-31745000

ABSTRACT

Background: The importance of medical research in developing academic and clinical excellence is widely acknowledged. Obstacles hindering research in primary care include negative attitudes, lack of dedicated time, funding shortages, and a relative paucity of mentors. Residency is the appropriate stage for developing research skills and encouraging research performance. In this article, we describe an intensive research training program offered at the family medicine (FM) Department, Technion Faculty of Medicine in Haifa, Israel. The program aims to engage residents in FM in constructing a research protocol to provide them with a positive experience, help them to overcome barriers, and enhance their research performance. Methods: Learning is achieved through a course design that includes the following six components: (1) course website: a platform for online collaborative learning; (2) inverted classroom: theory is learned through website video lectures and presentations during resident's own time according to a guided schedule, while weekly classroom sessions are dedicated to step-by-step implementation of theory, group discussion, and individual mentoring; (3) Peer feedback; (4) personal mentoring; (5) presentation of the protocol to peers and senior department staff at the end of the course; and (6) evaluation of protocol presentation and engagement during the research course as well as possibilities for further development. Results: Five teams of residents went on to conduct full research projects. Their studies have been presented at seven national and three international conferences, and one has been published. The outcomes of these studies have been useful in FM practices and have inspired residents to continue scholarly work in our department. Discussion: Innovation in teaching methods enhances engagement in learning research skills among residents and may encourage them to conduct research in primary care.


Subject(s)
Biomedical Research/education , Family Practice/education , Internship and Residency , Biomedical Research/methods , Humans , Internet , Israel , Mentoring , Teaching
6.
BMC Fam Pract ; 20(1): 51, 2019 04 05.
Article in English | MEDLINE | ID: mdl-30953452

ABSTRACT

BACKGROUND: Routine blood tests for young, healthy, asymptomatic patients have no proven value in early detection of diseases. Indeed, such tests have occasionally been found to be harmful. Although general blood tests are not recommended by evidence-based guidelines, patients frequently request referrals for these tests. A number of studies have examined the factors influencing doctors to prescribe such tests, yet little is known about patients' perspectives on this topic. The present study evaluated the knowledge, attitudes and beliefs of young, healthy asymptomatic patients requesting general blood tests from their family physician. METHOD: Qualitative interviews with 15 healthy, asymptomatic patients aged 22-50 who requested general blood tests from their family physicians. We conducted in-depth semi-structured interviews within two weeks of their request. RESULTS: Three main themes emerged from the interviews: 1) Patients' sense of personal responsibility and their belief that periodic blood tests are beneficial as an integral part of their health maintenance. 2) Patients' need to receive external, objective and reliable validation about what is happening inside their bodies. 3) An acquaintance's serious illness as a prompt to perform general blood tests in the belief that such tests can reveal latent conditions. CONCLUSION: The study revealed a substantial gap between patients' attitudes and beliefs about general blood tests and current evidence-based guidelines. Implications for research and practice are discussed.


Subject(s)
Diagnostic Tests, Routine , Health Knowledge, Attitudes, Practice , Patient Preference , Adult , Family Practice , Female , Humans , Male , Middle Aged , Physicians, Family , Qualitative Research , Young Adult
7.
J Prim Care Community Health ; 8(4): 221-227, 2017 Oct.
Article in English | MEDLINE | ID: mdl-29034793

ABSTRACT

BACKGROUND: Data on patients' utilization of health services in primary care is relevant to planning healthcare. Data may be collected by numerous methods, but obtaining a true picture of content of care has practical difficulties. OBJECTIVES: To describe patient's reasons for visits to primary care physicians (PCPs) as presented by the patient; and to examine the effect of patient-, doctor- and clinic-related variables on the reasons for the visit. METHODS: Visits to PCPs were observed by peer doctors during 2014, at primary care clinics in Israel. Data were collected on characteristics of physicians, patients, clinics, type of visit, and reasons for visit. RESULTS: Eleven physicians from 7 clinics participated in the study. Data were gathered from 327 visits. Patients visited for a wide variety of reasons. The most common acute complaints were upper respiratory symptoms, gastrointestinal, skin symptoms, and back and neck problems. The most common chronic complaints were hypertension and diabetes. Patients presented with administrative requests in 36% of visits; 15% were for solely administrative issues. A total of 26.6% of visits included requests for blood tests or discussion of tests. Patients initiated preventive medicine issues in 5% of visits. Visits for chronic problems were directly correlated with patient age and the extent of acquaintance with the physician. Gender-associated differences were also found: women were more likely to visit for a new medical problem than men, while men were more likely to visit for known or chronic problems. CONCLUSIONS: Patients visit their PCP for a wide variety of reasons, often during the same visit. Patients refer for administrative requests in about a third of visits. They initiate preventive care infrequently (1 out of 20 visits). To further characterize patient utilization of primary care, a broader study needs to be performed.


Subject(s)
Ambulatory Care , Office Visits , Primary Health Care/statistics & numerical data , Adolescent , Adult , Aged , Aged, 80 and over , Back Pain/epidemiology , Diabetes Mellitus/epidemiology , Female , Gastrointestinal Diseases/epidemiology , Hematologic Tests/statistics & numerical data , Humans , Hypertension/epidemiology , Israel/epidemiology , Male , Middle Aged , Neck Pain/epidemiology , Preventive Medicine/statistics & numerical data , Respiratory Tract Diseases/epidemiology , Sex Factors , Skin Diseases/epidemiology , Young Adult
8.
J Am Coll Cardiol ; 62(20): 1890-901, 2013 Nov 12.
Article in English | MEDLINE | ID: mdl-23973704

ABSTRACT

OBJECTIVES: This study sought to investigate the hypothesis that the favorable effects of mesenchymal stromal cells (MSCs) on infarct repair are mediated by macrophages. BACKGROUND: The favorable effects of MSC therapy in myocardial infarction (MI) are complex and not fully understood. METHODS: We induced MI in mice and allocated them to bone marrow MSCs, mononuclear cells, or saline injection into the infarct, with and without early (4 h before MI) and late (3 days after MI) macrophage depletion. We then analyzed macrophage phenotype in the infarcted heart by flow cytometry and macrophage secretome in vitro. Left ventricular remodeling and global and regional function were assessed by echocardiography and speckle-tracking based strain imaging. RESULTS: The MSC therapy significantly increased the percentage of reparative M2 macrophages (F4/80(+)CD206(+)) in the infarcted myocardium, compared with mononuclear- and saline-treated hearts, 3 and 4 days after MI. Macrophage cytokine secretion, relevant to infarct healing and repair, was significantly increased after MSC therapy, or incubation with MSCs or MSC supernatant. Significantly, with and without MSC therapy, transient macrophage depletion increased mortality 30 days after MI. Furthermore, early macrophage depletion produced the greatest negative effect on infarct size and left ventricular remodeling and function, as well as a significant incidence of left ventricular thrombus formation. These deleterious effects were attenuated with macrophage restoration and MSC therapy. CONCLUSIONS: Some of the protective effects of MSCs on infarct repair are mediated by macrophages, which are essential for early healing and repair. Thus, targeting macrophages could be a novel strategy to improve infarct healing and repair.


Subject(s)
Macrophages/physiology , Mesenchymal Stem Cell Transplantation , Myocardial Infarction/immunology , Myocardial Infarction/therapy , Regeneration/immunology , Animals , Female , Heart/physiology , Mice , Mice, Inbred BALB C
9.
Tissue Eng Part A ; 19(13-14): 1519-26, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23259631

ABSTRACT

Chronic wounds, particularly diabetic ulcers, represent a main public health concern with significant costs. Ulcers often harbor an additional obstacle in the form of tunneled or undermined wounds, requiring treatments that can reach the entire wound tunnel, because bioengineered grafts are typically available only in a sheet form. While collagen is considered a suitable biodegradable scaffold material, it is usually extracted from animal and human cadaveric sources, and accompanied by potential allergic and infectious risks. The purpose of this study was to test the performance of a flowable gel made of human recombinant type I collagen (rhCollagen) produced in transgenic tobacco plants, indicated for the treatment of acute, chronic, and tunneled wounds. The performance of the rhCollagen flowable gel was tested in an acute full-thickness cutaneous wound-healing rat model and compared to saline treatment and two commercial flowable gel control products made of bovine collagen and cadaver human skin collagen. When compared to the three control groups, the rhCollagen-based gel accelerated wound closure and triggered a significant jumpstart to the healing process, accompanied by enhanced re-epithelialization. In a cutaneous full-thickness wound pig model, the rhCollagen-based flowable gel induced accelerated wound healing compared to a commercial product made of bovine tendon collagen. By day 21 post-treatment, 95% wound closure was observed with the rhCollagen product compared to 68% closure in wounds treated with the reference product. Moreover, rhCollagen treatment induced an early angiogenic response and induced a significantly lower inflammatory response than in the control group. In summary, rhCollagen flowable gel proved to be efficacious in animal wound models and is expected to be capable of reducing the healing time of human wounds.


Subject(s)
Collagen/metabolism , Plants/chemistry , Wound Healing/physiology , Animals , Cattle , Collagen/chemistry , Collagen/genetics , Humans , Rats , Recombinant Proteins , Skin , Swine
10.
J Cardiovasc Transl Res ; 4(5): 559-74, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21656074

ABSTRACT

Induction of cardiac muscle regeneration following myocardial infarction (MI) represents a major challenge in cardiovascular therapy, as the current clinical approaches are limited in their ability to regenerate a new muscle tissue and to replace infarcted myocardium. Here, we describe the conception of two strategies based on bio-inspired materials, aimed at myocardial repair after MI. In the first strategy, alginate biomaterial was designed with affinity-binding moieties, enabling the binding of heparin-binding proteins and their controlled presentation and release. The combined features of this unique alginate hydrogel, as a temporary extracellular matrix replacement and a depot for bio-molecules such as insulin-like growth factor-1 and hepatocyte growth factor, led to improvements in cardiac structure and function, as demonstrated by the biomaterial's abilities to thicken the scar and prevent left-ventricular remodeling and dilatation. Endogenous regeneration occurring at the infarct as manifested by the enhanced angiogenesis, cardiomyocyte proliferation, and appearance of cardiac-related stem cells is likely to have contributed to this. In the second strategy, phosphatidylserine (PS)-presenting liposomes were developed to mimic apoptotic cells bodies, specifically their capability of immunomodulating activated macrophages into anti-inflammatory state. In a rat model of acute MI, targeting of PS-presenting liposomes to infarct macrophages after injection via the femoral vein was demonstrated by magnetic resonance imaging. The treatment promoted angiogenesis, the preservation of small scars, and prevention of ventricular dilatation and remodeling. Collectively, the two bio-inspired material-based strategies presented herein represent unique and clinical accessible approaches for myocardial infarct repair.


Subject(s)
Alginates , Biocompatible Materials , Bioengineering/methods , Myocardial Infarction/therapy , Myocardium/pathology , Phosphatidylserines , Regenerative Medicine/methods , Tissue Scaffolds , Animals , Disease Models, Animal , Drug Carriers , Extracellular Matrix Proteins/metabolism , Glucuronic Acid , Hexuronic Acids , Injections , Intercellular Signaling Peptides and Proteins/metabolism , Liposomes , Macrophages/immunology , Mice , Myocardial Infarction/immunology , Myocardial Infarction/metabolism , Myocardial Infarction/pathology , Myocardial Infarction/physiopathology , Myocardium/immunology , Myocardium/metabolism , Neovascularization, Physiologic , Rats , Regeneration , Time Factors , Ventricular Remodeling
11.
Proc Natl Acad Sci U S A ; 108(5): 1827-32, 2011 Feb 01.
Article in English | MEDLINE | ID: mdl-21245355

ABSTRACT

Herein we investigated a new strategy for the modulation of cardiac macrophages to a reparative state, at a predetermined time after myocardial infarction (MI), in aim to promote resolution of inflammation and elicit infarct repair. The strategy employed intravenous injections of phosphatidylserine (PS)-presenting liposomes, mimicking the anti-inflammatory effects of apoptotic cells. Following PS-liposome uptake by macrophages in vitro and in vivo, the cells secreted high levels of anti-inflammatory cytokines [transforming growth factor ß (TGFß) and interleukin 10 (IL-10)] and upregulated the expression of the mannose receptor--CD206, concomitant with downregulation of proinflammatory markers, such as tumor necrosis factor α (TNFα) and the surface marker CD86. In a rat model of acute MI, targeting of PS-presenting liposomes to infarct macrophages after injection via the femoral vein was demonstrated by magnetic resonance imaging (MRI). The treatment promoted angiogenesis, the preservation of small scars, and prevented ventricular dilatation and remodeling. This strategy represents a unique and accessible approach for myocardial infarct repair.


Subject(s)
Liposomes , Macrophages/physiology , Myocardial Infarction/pathology , Myocardium/pathology , Phosphatidylserines/administration & dosage , Animals , Enzyme-Linked Immunosorbent Assay , Female , Flow Cytometry , Immunohistochemistry , Interleukin-10/metabolism , Macrophages/metabolism , Mice , Mice, Inbred BALB C , Rats , Rats, Sprague-Dawley , Transforming Growth Factor beta/metabolism
12.
Tissue Eng Part A ; 15(4): 751-60, 2009 Apr.
Article in English | MEDLINE | ID: mdl-18636945

ABSTRACT

Developing advanced technologies for encouraging the ex vivo assembly of functional hepatic tissue for implantation into the human body or for in vitro drug testing is one of the challenging tasks facing tissue engineers. In the present study, we utilized a perfusion bioreactor system equipped with a novel flow-distributing mesh for online cell seeding into macroporous alginate scaffolds and cultivation of multiple constructs of the C3A human hepatocyte cell line. Optimization of the medium flow rate (100 mL/min) and perfusion duration (12 h) yielded cell constructs with high cell seeding efficiency (98% of the input cells) and cell distribution throughout the entire scaffold. Further, we show that interstitial medium flow enabled uniform cell delivery into 35 constructs lined across the bioreactor cross section. Perfusion-cultivated cell constructs revealed much greater rates of cell proliferation, albumin-specific secretion, and gene expression of the phase I enzyme, CYP3A4, and phase II enzyme, UGT2B7, than did static-cultivated constructs. Most impressive was the 50-fold increase in CYP3A4 expression of the perfused cell constructs as compared to the level in static-cultivated cell constructs. We thus believe that the hepatic tissue constructs developed herein may be used in drug discovery programs for elucidating drug metabolism and toxicity profiles and for treating failing livers.


Subject(s)
Bioreactors , Cell Culture Techniques/methods , Hepatocytes/cytology , Tissue Engineering/methods , Tissue Scaffolds , Cell Line , Cell Proliferation , Cytochrome P-450 CYP3A/metabolism , Glucuronosyltransferase/metabolism , Hepatocytes/metabolism , Humans , Immunohistochemistry , Microscopy, Fluorescence , Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...